Is Erasca, Inc. (ERAS) a Buy, Sell, or Hold?
Erasca, Inc.
NASDAQ:ERAS
$19.5 USD
$1.6 (8.94%)
- Volume
- 10.98M
- Average Volume
- 7M
- Market Capitalization
- $6.06B
- P/E Ratio
- -20.97
- Dividend Yield
- 0.00%
- Price Target
- $18.00
- Year High
- $24.28
- Year Low
- $1.33
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.52
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
23
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
5
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 306.2K
ERAS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ERAS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Start Valerie Denise Harding | director | 2026-06-26 | A-Award | 16.01 | 2026-06-29 |
| LIU JEAN I | director | 2026-06-26 | A-Award | 16.01 | 2026-06-29 |
| Multani Pratik S | director | 2026-06-26 | A-Award | 16.01 | 2026-06-29 |
| Casdin Alexander W. | director | 2026-06-26 | A-Award | 16.01 | 2026-06-29 |
| Hambleton Julie | director | 2026-06-26 | A-Award | 16.01 | 2026-06-29 |
| Bristol James Arthur | director | 2026-06-26 | A-Award | 16.01 | 2026-06-29 |
| Garner Ebun | officer: Chief Legal Officer | 2026-04-01 | M-Exempt | 1.7 | 2026-04-03 |
| Garner Ebun | officer: Chief Legal Officer | 2026-04-01 | M-Exempt | 1.7 | 2026-04-03 |
| Garner Ebun | officer: Chief Legal Officer | 2026-04-01 | S-Sale | 16.4 | 2026-04-03 |
| Morris Shannon | officer: Chief Medical Officer | 2025-03-04 | M-Exempt | 1.7 | 2026-03-06 |
| Morris Shannon | officer: Chief Medical Officer | 2026-03-04 | M-Exempt | 1.7 | 2026-03-06 |
| Morris Shannon | officer: Chief Medical Officer | 2026-03-04 | S-Sale | 15.038 | 2026-03-06 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2026-01-29 | A-Award | 10.31 | 2026-01-30 |
| Chacko David M. | officer: CFO and CBO | 2026-01-29 | A-Award | 10.31 | 2026-01-30 |
| Chacko David M. | officer: CFO and CBO | 2025-12-15 | J-Other | 1.1943 | 2026-01-30 |
| Morris Shannon | officer: Chief Medical Officer | 2026-01-29 | A-Award | 10.31 | 2026-01-30 |
| Varney Michael David | director | 2026-01-29 | A-Award | 10.31 | 2026-01-30 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2026-01-29 | A-Award | 10.31 | 2026-01-30 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2025-01-07 | M-Exempt | 1.7 | 2026-01-08 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2026-01-07 | M-Exempt | 1.7 | 2026-01-08 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2026-01-07 | S-Sale | 5.5901 | 2026-01-08 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2025-12-15 | A-Award | 1.1943 | 2026-01-08 |
| Bristol James Arthur | director | 2026-01-01 | A-Award | 3.72 | 2026-01-05 |
| LIU JEAN I | director | 2026-01-01 | A-Award | 3.72 | 2026-01-05 |
| Multani Pratik S | director | 2026-01-01 | A-Award | 3.72 | 2026-01-05 |
| Start Valerie Denise Harding | director | 2026-01-01 | A-Award | 3.72 | 2026-01-05 |
| Casdin Alexander W. | director | 2026-01-01 | A-Award | 3.72 | 2026-01-05 |
| Varney Michael David | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| LIU JEAN I | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| Hambleton Julie | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| Start Valerie Denise Harding | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| Multani Pratik S | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| Bristol James Arthur | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| Casdin Alexander W. | director | 2025-06-24 | A-Award | 1.45 | 2025-06-26 |
| Multani Pratik S | director | 2025-05-23 | G-Gift | 0 | 2025-06-03 |
| Multani Pratik S | director | 2025-05-23 | G-Gift | 0 | 2025-06-03 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2025-02-13 | A-Award | 1.63 | 2025-02-18 |
| Chacko David M. | officer: CFO and CBO | 2025-02-03 | A-Award | 1.76 | 2025-02-05 |
| Chacko David M. | officer: CFO and CBO | 2024-12-13 | J-Other | 1.564 | 2025-02-05 |
| Morris Shannon | officer: Chief Medical Officer | 2025-02-03 | A-Award | 1.76 | 2025-02-05 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2025-02-03 | A-Award | 1.76 | 2025-02-05 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2024-12-13 | J-Other | 1.564 | 2025-02-05 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2025-02-03 | A-Award | 1.76 | 2025-02-05 |
| Casdin Alexander W. | director | 2025-01-01 | A-Award | 2.51 | 2025-01-02 |
| LIU JEAN I | director | 2025-01-01 | A-Award | 2.51 | 2025-01-02 |
| Start Valerie Denise Harding | director | 2025-01-01 | A-Award | 2.51 | 2025-01-02 |
| Bristol James Arthur | director | 2025-01-01 | A-Award | 2.51 | 2025-01-02 |
| Varney Michael David | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Start Valerie Denise Harding | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| LIU JEAN I | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Morris Shannon | officer: Chief Medical Officer | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Chacko David M. | officer: CFO and CBO | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Hambleton Julie | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Casdin Alexander W. | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Bristol James Arthur | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Multani Pratik S | director | 2024-06-20 | A-Award | 2.03 | 2024-06-21 |
| Casdin Alexander W. | director | 2024-05-21 | P-Purchase | 2.274 | 2024-05-22 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2024-02-05 | A-Award | 1.7 | 2024-02-07 |
| Chacko David M. | officer: CFO and CBO | 2024-02-05 | A-Award | 1.7 | 2024-02-07 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2024-02-05 | A-Award | 1.7 | 2024-02-07 |
| Morris Shannon | officer: Chief Medical Officer | 2024-02-05 | A-Award | 1.7 | 2024-02-07 |
| Bristol James Arthur | director | 2024-01-01 | A-Award | 2.13 | 2024-01-03 |
| Multani Pratik S | director | 2024-01-01 | A-Award | 2.13 | 2024-01-03 |
| LIU JEAN I | director | 2024-01-01 | A-Award | 2.13 | 2024-01-03 |
| Start Valerie Denise Harding | director | 2024-01-01 | A-Award | 2.13 | 2024-01-03 |
| Casdin Alexander W. | director | 2024-01-01 | A-Award | 2.13 | 2024-01-03 |
| Chacko David M. | officer: CFO and CBO | 2023-12-15 | J-Other | 1.5895 | 2023-12-18 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2023-12-15 | J-Other | 1.5895 | 2023-12-18 |
| Start Valerie Denise Harding | director | 2023-12-06 | P-Purchase | 1.848 | 2023-12-08 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-12-05 | P-Purchase | 1.687 | 2023-12-06 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-12-06 | P-Purchase | 1.72 | 2023-12-06 |
| Casdin Alexander W. | director | 2023-12-04 | P-Purchase | 1.6595 | 2023-12-04 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-10-05 | P-Purchase | 2.026 | 2023-10-10 |
| Chen Bihua | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Varney Michael David | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Multani Pratik S | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| LIU JEAN I | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-03-28 | 0 | 2023-06-26 | |
| Start Valerie Denise Harding | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Hambleton Julie | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Casdin Alexander W. | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Bristol James Arthur | director | 2023-06-22 | A-Award | 2.66 | 2023-06-26 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-06-08 | P-Purchase | 2.75 | 2023-06-08 |
| Morris Shannon | officer: Chief Medical Officer | 2023-04-10 | A-Award | 2.735 | 2023-04-13 |
| Morris Shannon | officer: Chief Medical Officer | 2023-04-10 | 7.91 | 2023-04-13 | |
| Morris Shannon | officer: Chief Medical Officer | 2023-04-10 | 4 | 2023-04-13 | |
| Casdin Alexander W. | director | 2023-04-10 | P-Purchase | 2.7615 | 2023-04-11 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-03-28 | P-Purchase | 2.84 | 2023-03-28 |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman and CEO | 2022-12-31 | 0 | 2023-02-15 | |
| Lim Jonathan E | director, 10 percent owner, officer: Chairman & CEO | 2023-02-01 | A-Award | 4 | 2023-02-03 |
| Chacko David M. | officer: Chief Financial Officer | 2023-02-01 | A-Award | 4 | 2023-02-03 |
| Chacko David M. | officer: Chief Financial Officer | 2023-02-01 | J-Other | 3.893 | 2023-02-03 |
| Chacko David M. | officer: Chief Financial Officer | 2023-02-01 | J-Other | 4.097 | 2023-02-03 |
| Wei Lin | officer: Chief Medical Officer | 2023-02-01 | A-Award | 4 | 2023-02-03 |
| Wei Lin | officer: Chief Medical Officer | 2023-02-01 | J-Other | 4.097 | 2023-02-03 |
| Wei Lin | officer: Chief Medical Officer | 2023-02-01 | J-Other | 3.893 | 2023-02-03 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2023-02-01 | A-Award | 4 | 2023-02-03 |
| Garner Ebun | officer: General Counsel & Corp. Sec. | 2023-02-01 | J-Other | 4.097 | 2023-02-03 |